HiberCell Competitors and Similar CompaniesClear all
HiberCell's competitors and similar companies include Eisbach Bio, PEP-Therapy, Rain Therapeutics and Odyssey Therapeutics.
 HiberCell HiberCell is a company that focuses on therapeutically modulating the biology and mechanisms of tumor dormancy. |  Eisbach Bio Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes. |  PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. |  Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. | |
Founding Date | Founding Date 2019 | Founding Date 2019 | Founding Date 2014 | Founding Date 2017 | Founding Date 2021 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ Roseville, US | Locations Planegg, DE HQ | Locations Paris, FR HQ Évry, FR | Locations Newark, US HQ | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US |
Employees | Employees 264% decrease | Employees 118% decrease | Employees 14 | Employees 6343% increase | Employees 1481% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 67.4m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 3m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 128.2m | Total funding raised N/A | Total funding raised $ 3m | Total funding raised $ 82.4m | Total funding raised $ 386m |
For sources of this data, please see the company profile
View Company Profiles
Eisbach Bio
HQ
Planegg, DE
Employees
11↓ 8% decrease
Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes.
View companyPEP-Therapy
HQ
Paris, FR
Employees
14
PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.
View companyRain Therapeutics
HQ
Newark, US
Employees
63↑ 43% increase
Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View company